ERBB2 and breast cancer: Breast cancer diagnosed through histopathological analysis in female under the age of 40 years old are defined as early-onset breast cancer which is strongly linked to aggressive triple-negative or human epidermal growth factor 2 (HER2)-positive tumors [3].